Hi Guest Login
Home > Tests > Factor II Functional (L) > Delhi
₹8960 ₹7168
Report Time
Report by FriFREE
Home Sample Collection
Age Group
Parameters Included
1
Recomended for
Both
Fasting
10 -12 hrs of Fasting Required
Report Time
Report by Fri
Exclusive Offer
₹7168
₹8960
FREE Home Sample Collection*
FREE Smart Report
Get a callback from our Health advisor.
Understanding the Test
Test Measures
City Price Info
The Factor II (Prothrombin) Functional Test is a specialized coagulation test that measures the activity of Factor II (prothrombin), a key clotting protein produced by the liver that plays an essential role in the blood coagulation process. This diagnostic service is readily available across Delhi, providing patients with convenient access to accurate coagulation assessments. Unlike genetic tests that identify inherited mutations, this functional assay evaluates how effectively prothrombin is working in the body. The test is vital for those in Delhi needing to diagnose clotting disorders, investigate unexplained bleeding, assess liver function, monitor anticoagulant therapy, and support the evaluation of inherited or acquired Factor II deficiencies.
The Factor II (Prothrombin) Functional Test measures the functional activity of prothrombin in the bloodstream, indicating how effectively this clotting factor contributes to normal blood coagulation. By leveraging widespread healthcare accessibility in Delhi, including options for professional at-home sample collection, this test helps determine whether Factor II levels are sufficient and functioning properly. These results are critical for aiding in the diagnosis of bleeding disorders, coagulation abnormalities, liver-related clotting issues, vitamin K deficiency, and various conditions affecting the body's ability to form stable blood clots for residents across the capital.
The Factor II Functional Test (also known as the prothrombin assay) is a specialized coagulation test that measures the activity level of Factor II (prothrombin) in the blood. Factor II is a vitamin K-dependent glycoprotein produced by the liver that plays a central role in the blood clotting cascade.
Unlike genetic tests that detect mutations (such as the Factor II G20210A mutation linked to thrombophilia), the functional test measures how well the protein actually works, providing real-world information about clotting ability rather than just genetic risk.
The Factor II (Prothrombin) functional test plays an important role in evaluating blood clotting and identifying underlying causes of bleeding or coagulation abnormalities. The following are the key clinical situations where this test is commonly used:
The Factor II functional test diagnoses prothrombin deficiency, inherited or acquired. Congenital deficiency is rare and may cause mild to severe bleeding depending on activity levels. Acquired causes, including vitamin K deficiency, liver disease, DIC, and anticoagulant use, are more common. The test confirms reduced or dysfunctional Factor II activity and guides diagnosis.
When PT or INR is prolonged, this test helps identify if Factor II deficiency is the cause. Since PT reflects multiple clotting factors, measuring Factor II directly allows clinicians to pinpoint the exact abnormality and differentiate it from other causes like vitamin K deficiency or liver dysfunction.
Factor II is produced in the liver, so its level reflects liver function. Reduced activity may indicate impaired protein synthesis in conditions such as cirrhosis or hepatitis. The test helps assess disease severity, bleeding risk, and monitor liver health.
Warfarin reduces Factor II production as part of its anticoagulant effect. While INR is commonly used for monitoring, Factor II testing provides a more accurate assessment when INR is unreliable, such as in patients with lupus anticoagulants.
The test helps evaluate patients with unexplained bleeding or those undergoing surgery. Identifying a Factor II deficiency allows clinicians to plan preventive measures, such as clotting factor replacement, to reduce bleeding complications.
In autoimmune conditions, some patients develop antibodies against Factor II, causing reduced levels and bleeding risk. The test detects this condition and supports management of both bleeding and clotting risks.
Overall, the Factor II functional test goes beyond simple screening. It provides a measurable assessment of clotting capacity. Providing quantitative data empowers doctors to make precise, timely, and individualized clinical decisions for patients with bleeding or thrombotic disorders.
Coagulation disorders often present with bleeding or clotting symptoms that may be mistaken for other conditions. The Factor II test is ordered when a person has persistent unexplained bleeding or abnormal coagulation screening results.
Bruising from minor bumps or without a known cause is a common early sign of Factor II deficiency. Patients may notice bruises frequently on arms, legs, or trunk without significant trauma.
Bleeding that continues longer than expected after a cut, dental extraction, or surgical procedure may indicate a coagulation factor deficiency. This is often the first clue that leads to testing.
Recurrent nosebleeds that are difficult to control or require medical attention can be a symptom of mild to moderate Factor II deficiency. These may occur spontaneously or with minimal irritation.
Women with Factor II deficiency often have unusually heavy or prolonged menstrual periods, sometimes requiring medical intervention or causing iron deficiency anemia.
Gums that bleed easily with brushing, flossing, or spontaneously without an obvious cause may indicate a clotting problem rather than dental issues.
Unexplained blood in the stool (which may appear red or black/tarry) or blood in the urine (visible or detected on a dipstick test) warrants evaluation for a bleeding disorder.
In severe congenital Factor II deficiency, affected newborns may experience prolonged bleeding from the umbilical cord stump—a finding that often leads to early diagnosis.
Spontaneous bleeding into muscles or joints, causing pain and swelling, is rare but can occur in individuals with very low Factor II activity (typically less than 30% of normal).
A family history of Factor II deficiency (inherited as an autosomal recessive trait) or other coagulation abnormalities should prompt testing in symptomatic individuals.
When routine blood tests show prolonged PT or INR without an obvious cause like warfarin therapy, Factor II testing helps identify the underlying deficiency.
Some coagulation disorders, including Factor II abnormalities, are associated with pregnancy loss and other obstetric complications, prompting testing in affected women.
The Factor II Functional Test measures the activity level of prothrombin in the blood. Results are typically reported as a percentage (%) of normal pooled plasma or in international units (IU/mL) .
|
Parameter |
Description |
Clinical Significance |
|
Factor II Activity (%) |
Percentage of normal Factor II function in patient plasma compared to standard reference plasma |
Low levels indicate deficiency; high levels may indicate thrombotic risk |
|
Clotting Time |
Time measured in a one-stage PT-based clotting assay |
Prolonged time suggests Factor II deficiency or the presence of an inhibitor |
|
Dilution Parallelism |
Assessment of assay linearity across multiple dilutions |
Non-parallelism may indicate the presence of inhibitors affecting Factor II |
This test is recommended for individuals with clinical features suggestive of a bleeding or clotting disorder, especially those with abnormal coagulation screening tests.
Individuals who experience easy bruising, frequent nosebleeds, prolonged bleeding from minor cuts, or heavy menstrual periods should be evaluated for Factor II deficiency.
When routine coagulation testing shows an isolated prolonged prothrombin time (PT) with a normal aPTT, the Factor II assay helps identify the specific factor deficiency.
Individuals diagnosed with cirrhosis, hepatitis, or other liver conditions may have acquired Factor II deficiency due to impaired protein synthesis. Testing helps assess bleeding risk and guide management.
Patients with malabsorption syndromes (celiac disease and Crohn's disease), prolonged antibiotic use, or poor nutritional intake may develop vitamin K deficiency, leading to low Factor II levels.
Patients who develop deep vein thrombosis (DVT), pulmonary embolism (PE), or other abnormal blood clots without clear risk factors may have elevated Factor II levels contributing to hypercoagulability.
Before elective surgery or dental procedures, patients with a personal or family history of bleeding problems may undergo Factor II testing to assess bleeding risk.
Infants who experience prolonged bleeding from the umbilical cord stump after birth should be evaluated for severe congenital Factor II deficiency.
The following table provides a quick overview of the key details of the Factor II Functional Test
|
Parameter |
Details |
|
Test Name |
Factor II (Prothrombin) Functional Test |
|
Also Known As |
Factor II Activity, Prothrombin Assay, FII Assay |
|
Sample Type |
Plasma (citrated)—Light blue-top tube (3.2% sodium citrate) |
|
Gender |
Both |
|
Age Group |
All (reference ranges vary by age) |
|
Fasting Required |
10-12 hours fasting is advised |
|
Report Time |
48–72 Hours |
|
Home Collection |
Available |
Factor II activity is measured as a percentage, with normal ranges typically 50%-150%, though this may vary by laboratory. Low levels indicate a risk of bleeding due to deficiency, while higher levels are less common and may be associated with an increased tendency to clot.
|
Category |
Reference Range (Activity) |
Notes |
|
Normal |
50% – 150% (0.5 – 1.50 IU/mL) |
Typical adult range |
|
Low |
<50% |
Potential for bleeding or deficiency |
|
High |
>150% |
Generally not associated with high bleeding risk |
Note: Normal ranges may vary slightly between laboratories. Always discuss your results with your doctor.
Several factors can influence the accuracy and interpretation of Factor II functional test results.
|
Factor |
Effect on Result |
|
Anticoagulant Medications |
Warfarin, direct oral anticoagulants (DOACs), and heparin cause falsely low Factor II activity levels |
|
Liver Disease |
Impaired hepatic synthesis leads to decreased Factor II activity |
|
Vitamin K Deficiency |
Results in decreased activity of all vitamin K-dependent factors, including Factor II |
|
Lupus Anticoagulants |
May cause falsely low Factor II levels due to antibody-mediated clearance |
|
Sample Collection Issues |
Underfilled citrate tubes, clotted samples, or hemolysis can invalidate results |
|
Sample Handling |
Delayed processing or improper storage can degrade Factor II activity |
|
Timing of Test |
Testing during acute illness or DIC may show transiently low levels |
|
Laboratory Method |
Different assays (one-stage clotting vs. chromogenic) may yield slightly different results |
Factor II results are reported as a percentage of normal activity. Interpretation should always be performed by a hematologist or physician, taking into account clinical symptoms and medication history.
|
Result Range |
Interpretation |
Possible Causes |
Next Steps |
|
Normal (60–130%) |
Factor II activity within expected range |
No deficiency detected |
Clinical correlation needed; consider other causes if bleeding persists |
|
Mildly Low (30–50%) |
Mild Factor II deficiency |
Heterozygous congenital deficiency, early liver disease, vitamin K deficiency, warfarin therapy |
Clinical correlation; may cause minor bleeding with trauma/surgery |
|
Moderately Low (10–30%) |
Moderate Factor II deficiency |
Homozygous congenital deficiency, significant liver disease, DIC |
Increased bleeding risk; may require treatment before procedures |
|
Severely Low (<10%) |
Severe Factor II deficiency |
Severe homozygous deficiency, advanced liver failure |
High risk of spontaneous bleeding; requires specialist management |
|
Elevated (>130–150%) |
High Factor II activity |
Genetic polymorphism (G20210A mutation), inflammation |
Increased risk of venous thromboembolism (DVT/PE) |
Special Considerations
Heterozygous vs. Homozygous Deficiency
Choosing the right diagnostic provider is essential for accurate coagulation testing and reliable results.
Sample collection is performed by trained professionals who follow strict coagulation protocols, including proper tube filling and gentle mixing to prevent clotting.
All samples are processed in NABL-accredited laboratories using validated one-stage clotting assays for high accuracy and reproducibility.
MAX@Home ensures proper sample handling, including double centrifugation to obtain platelet-poor plasma and frozen transport, essential for accurate Factor II results.
Schedule your test at a convenient time with doorstep sample collection, eliminating hospital visits.
From booking to report delivery, MAX@Home provides full support throughout the process.
Reports are typically delivered within 48–72 hours, enabling timely hematology consultation.
Backed by Max Healthcare's clinical expertise, MAX@Home brings hospital-grade diagnostics to your home.
Early and accurate diagnosis of bleeding or clotting disorders can prevent complications, guide safe surgery, and improve long-term outcomes. Do not ignore unexplained bleeding or abnormal clotting results.
Read More
You've selected items to compare.
View All
MAX@Home is one of Delhi’s leading providers of diagnostic services, with lab-test centres located across all major localities in the city.